---
layout: post
title: "Over-the-Counter Monograph Drug User Fee Rates for Fiscal Year 2023"
date: 2026-02-05 18:36:02 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-06299
original_published: 2023-03-27 00:00:00 +0000
significance: 8.00
---

# Over-the-Counter Monograph Drug User Fee Rates for Fiscal Year 2023

**Published:** February 05, 2026 18:36 UTC
**Source:** Federal Register
**Original Published:** March 27, 2023 00:00 UTC
**Document Number:** 2023-06299

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the fee rates under the over-the-counter (OTC) monograph drug user fee program (OMUFA) for fiscal year (FY) 2023. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters of OTC monograph order requests. This notice publishes the OMUFA fee rates for FY 2023.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/27/2023-06299/over-the-counter-monograph-drug-user-fee-rates-for-fiscal-year-2023)
- API: https://www.federalregister.gov/api/v1/documents/2023-06299

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
